UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | E | F | G | K | S | W
Number of items: 17.

A

Anderson, FA; Goldhaber, SZ; Tapson, VF; Bergmann, JF; Kakkar, AK; Deslandes, B; ... ENDORSE Investigators,; + view all (2010) Improving Practices in US Hospitals to Prevent Venous Thromboembolism: Lessons from ENDORSE. AM J MED , 123 (12) 1099 - +. 10.1016/j.amjmed.2010.07.011.

B

Bergmann, JF; Cohen, AT; Tapson, VF; Goldhaber, SZ; Kakkar, AK; Deslandes, B; ... ENDORSE Investigators,; + view all (2010) Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb Haemost , 103 (4) 736 - 748. 10.1160/TH09-09-0667.

C

Castonguay, A; Kakkar, AK; (2010) Dendrimer templated construction of silver nanoparticles. ADV COLLOID INTERFAC , 160 (1-2) 76 - 87. 10.1016/j.cis.2010.07.006.

E

Eriksson, BI; Kakkar, A; Turpie, AGG; Gent, M; Lassen, MR; (2010) Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement Reply. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME , 92B (3) 468 - 468. 10.1302/0301-620X.92B3.24658.

F

Franc, G; Kakkar, AK; (2010) "Click'' methodologies: efficient, simple and greener routes to design dendrimers. CHEM SOC REV , 39 (5) 1536 - 1544. 10.1039/b913281n.

G

Gooding, KM; Tooke, JE; von Lany, H; Mitra, M; Ling, R; Ball, CI; ... Shore, AC; + view all (2010) Capillary pressure may predict preclinical changes in the eye. DIABETOLOGIA , 53 (9) 2029 - 2035. 10.1007/s00125-010-1805-x.

K

Kakkar, AK; (2010) Cancer-associated thrombosis Introduction. BRIT J CANCER , 102 S1 - S1. 10.1038/sj.bjc.6605598.

Kakkar, AK; Agnelli, G; Fisher, WD; George, D; Mouret, P; Lassen, MR; ... Turpie, AGG; + view all (2010) The Ultra Low Molecular Weight Heparin Semuloparin for Prevention of Venous Thromboembolism In Patients Undergoing Major Abdominal Surgery. In: BLOOD. (pp. 86 - 86). AMER SOC HEMATOLOGY

Kakkar, AK; Agnelli, G; Fisher, WD; George, D; Mouret, P; Lassen, MR; ... Turpie, AGG; + view all (2010) The Ultra-Low-Molecular-Weight Heparin Semuloparin for Prevention of Venous Thromboembolism In Patients Undergoing Major Abdominal Surgery. In: BLOOD. (pp. 86 - 86). AMER SOC HEMATOLOGY

Kakkar, AK; Cohen, AT; Tapson, VF; Bergmann, JF; Goldhaber, S; Deslandes, B; ... ENDORSE Investigators,; + view all (2010) Venous Thromboembolism Risk and Prophylaxis in the Acute Care Hospital Setting (ENDORSE Survey) Findings in Surgical Patients. ANN SURG , 251 (2) 330 - 338. 10.1097/SLA.0b013e3181c0c58f.

Kakkar, AK; Cohen, AT; Tapson, VF; Bergmann, JF; Goldhaber, SZ; Deslandes, B; ... ENDORSE Investigators,; + view all (2010) Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients. Ann Surg , 251 (2) 330 - 338. 10.1097/SLA.0b013e3181c0e58f.

Kakkar, AK; Doval, DC; Fareed, J; Kerr, D; Maganji, JM; Mueller, I; (2010) RATIONALE AND DESIGN OF THE GASTRANOX TRIAL ON A LOW-MOLECULAR-WEIGHT HEPARIN [LMWH], ENOXAPARIN, WITH CHEMOTHERAPY VS. CHEMOTHERAPY ALONE IN INOPERABLE GASTRIC AND GASTRO-OESOPHAGEAL CANCER. In: ANNALS OF ONCOLOGY. (pp. 252 - 253). OXFORD UNIV PRESS

Kakkar, AK; Macbeth, F; (2010) Antithrombotic therapy and survival in patients with malignant disease. BRIT J CANCER , 102 S24 - S29. 10.1038/sj.bjc.6605602.

S

Singh, M; Mandal, S; Kakkar, AK; Khurana, N; Garg, A; (2010) Mixed corticomedullary tumour with myelolipoma: a rare coexistence. PATHOLOGY , 42 (6) 589 - 591. 10.3109/00313025.2010.508741.

Soliman, GM; Sharma, R; Choi, AO; Varshney, SK; Winnik, FM; Kakkar, AK; Maysinger, D; (2010) Tailoring the efficacy of nimodipine drug delivery using nanocarriers based on A(2)B miktoarm star polymers. BIOMATERIALS , 31 (32) 8382 - 8392. 10.1016/j.biomaterials.2010.07.039.

W

Whiteman, M; Gooding, KM; Whatmore, JL; Ball, CI; Mawson, D; Skinner, K; ... Shore, AC; + view all (2010) Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. DIABETOLOGIA , 53 (8) 1722 - 1726. 10.1007/s00125-010-1761-5.

Whiteman, M; Gooding, KM; Whatmore, JL; Skinner, K; Ball, C; Tooke, JE; Shore, AC; (2010) PLASMA LEVELS OF THE NOVEL VASODILATORY GAS HYDROGEN SULPHIDE ARE ASSOCIATED WITH ADIPOSITY. In: HEART. (pp. ? - ?). B M J PUBLISHING GROUP

This list was generated on Sun Sep 14 01:29:21 2014 BST.